[Secondary growing and metabolic effects of phagocytised microcrystalline glucocorticoid (9 -fluor-16 , 17 -isopropylidene-dioxyprednisolon) on permanent fibroblast cultures].
D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002417:Cattle; D002452:Cell Count; D002460:Cell Line; D002478:Cells, Cultured / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects* / Q000254:growth & development; D005947:Glucose / Q000378:metabolism; D066298:In Vitro Techniques; D007739:L Cells; D007773:Lactates / Q000378:metabolism; D008938:Mitosis / Q000187:drug effects; D010101:Oxygen Consumption / Q000187:drug effects; D010587:Phagocytosis; D011773:Pyruvates / Q000378:metabolism; D014222:Triamcinolone Acetonide / Q000378:metabolism / Q000494:pharmacology*
D007773:Lactates; D011773:Pyruvates; D014222:Triamcinolone Acetonide; D005947:Glucose
Die sekundäre Wachstums- und Stoffwechselwirkung von phagocytiertem mikrokristallinen glocucorticoid (9 -fluor-16 , 17 -isopropyliden-dioxyprednisolon) auf permanente Fibroblastenkulturen.